Brief: Harvard Bioscience Announces Third Quarter 2022 Financial Results
08/11/2022 23:07
Nov 8 (Reuters) - Harvard Bioscience Inc HBIO.O :
* HARVARD BIOSCIENCE ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
* HARVARD BIOSCIENCE INC - QTRLY LOSS PER SHARE $0.08
* HARVARD BIOSCIENCE INC - QTRLY ADJUSTED LOSS PER SHARE
$0.01
* HARVARD BIOSCIENCE INC - QTRLY REVENUE $26.9 MILLION
VERSUS
$29.7 MILLION
Source text for Eikon: ID:nGNX1xwQyf
Further company coverage: HBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance